Viemed Healthcare, Inc. VMD Supplier Finance Program Obligations

Supplier Finance Program Obligations at other companies

Xerox Holdings CorporationXRX

1,800,000,000%-100,000,000pp

Edgewell Personal CareEPC

1,550,000,000%+1,549,998,250pp

Monro, Inc.MNRO

$226.8M-7.6%

McCormick & Company, IncorporatedMKC

33,210,000,000%-8,530,000,000pp

TerexTEX

4,400,000,000%+800,000,000pp

Tyson FoodsTSN

5,200,000,000%+700,000,000pp

Other financials

Income statement

See full

Revenue$75.4M+27.5%

Gross profit$42.8M+28.7%

Operating income$4.3M+11.8%

Net income$2.6M-1.6%

EPS (diluted)$0.060.0%

Balance sheet

See full

Cash & equivalents$9.8M-3.9%

Total debt$12.4M+84.0%

Total equity$143.9M+6.8%

Total assets$197.4M+10.8%

Cash flow

See full

Operating cash flow$8.1M+183%

CapEx$6.7M-56.6%

Free cash flow$1.4M+111%

Valuation

See full

Market cap$448.16M+71.3%

Enterprise value$450.83M+74.6%

P/E30.1×+8.8×

P/S1.6×+0.4×

Profitability

See full

Gross margin57.6%-1.1pp

Operating margin8.2%-0.2pp

Net margin5.2%-0.1pp

FCF margin9%—

Returns & leverage

See full

Return on equity10.7%+0.9pp

Debt / equity0.1×0.0×

Current ratio1.2×-0.2×

Where this comes from

Reported directly by Viemed Healthcare, Inc. in its filing.

Tagged under the XBRL concept us-gaap:SupplierFinanceProgramObligationCurrent.

The official record: Viemed Healthcare, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viemed Healthcare, Inc.'s supplier finance program obligations.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Viemed Healthcare, Inc.'s supplier finance program obligations?: Viemed Healthcare, Inc. (VMD) reported supplier finance program obligations of $600K in Q1 2026.